| |
Number
|
Percentage
|
|---|
|
Age/years
|
60 (21–82)
|
|
Sex
|
|
• Male
|
29
|
47.5
|
|
• Female
|
32
|
52.6
|
|
Clinical presentation
|
|
• Jaundice
|
43
|
70.5
|
|
• Upper abdominal pain
|
10
|
16.4
|
|
• Incidental biliary dilatation
|
8
|
13.1
|
|
History of cholecystectomy
|
6
|
9.8
|
|
Laboratory data
|
|
• Bilirubin (total) (mg/dl)
|
2.8 (0.4–39)
|
|
• ALT (IU/l)
|
49 (11–293)
|
|
• AST (IU/l)
|
47 (19–288)
|
|
• Alkaline phosphatase (mg/dl)
|
223.0 (47–1260 )
|
|
• Tumor markers
|
|
CA19-9
|
39.0 (0.60–1200)
|
|
CEA
|
2.69 (0.4–15.05)
|
- Data are expressed as mean ± SD, median (range), or n (%)
- ALT Alanine transaminase, AST Aspartate aminotransferase, CA19-9 Carbohydrate antigen 19-9, CEA Carcinoembryonic antigen
